Literature DB >> 8370864

A phase model of psychotherapy outcome: causal mediation of change.

K I Howard1, R J Lueger, M S Maling, Z Martinovich.   

Abstract

A 3-phase model of psychotherapy outcome is proposed that entails progressive improvement of subjectively experienced well-being, reduction in symptomatology, and enhancement of life functioning. The model also predicts that movement into a later phase of treatment depends on whether progress has been made in an earlier phase. Thus, clinical improvement in subjective well-being potentiates symptomatic improvement, and clinical reduction in symptomatic distress potentiates life-functioning improvement. A large sample of psychotherapy patients provided self-reports of subjective well-being, symptomatic distress, and life functioning before beginning individual psychotherapy and after Sessions 2, 4, and 17 when possible. Changes in well-being, symptomatic distress, and life functioning means over this period were consistent with the 3-phase model. Measures of patient status on these 3 variables were converted into dichotomous improvement-nonimprovement scores between intake and each of Sessions 2, 4, and 17. An analysis of 2 x 2 cross-classification tables generated from these dichotomous measures suggested that improvement in well-being precedes and is a probabilistically necessary condition for reduction in symptomatic distress and that symptomatic improvement precedes and is a probabilistically necessary condition for improvement in life functioning.

Entities:  

Mesh:

Year:  1993        PMID: 8370864     DOI: 10.1037//0022-006x.61.4.678

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  37 in total

1.  Psychotherapy by psychiatrists in a managed care environment: must it be an oxymoron? A forum from the APA commission on Psychotherapy by Psychiatrists. American Psychiatric Association.

Authors:  N A Clemens; K R MacKenzie; J L Griffith; J C Markowitz
Journal:  J Psychother Pract Res       Date:  2001

2.  Private practitioners' documentation of outpatient psychiatric treatment: questioning managed care.

Authors:  R H Keefe; M L Hall
Journal:  J Behav Health Serv Res       Date:  1999-05       Impact factor: 1.505

3.  The effect of technical support on clinician attitudes toward an outcome assessment instrument.

Authors:  Jennifer L Close-Goedjen; Stephen M Saunders
Journal:  J Behav Health Serv Res       Date:  2002-02       Impact factor: 1.505

4.  "Ready, willing, and (not) able" to change: young adults' response to residential treatment.

Authors:  J F Kelly; K A Urbanoski; B B Hoeppner; V Slaymaker
Journal:  Drug Alcohol Depend       Date:  2011-09-28       Impact factor: 4.492

5.  Longitudinal Analysis when the Experimenter does not Determine when Treatment Ends: What is Dose-Response?

Authors:  Daniel J Feaster; Frederick L Newman; Christopher Rice
Journal:  Clin Psychol Psychother       Date:  2003

6.  The Hoosier Assurance Plan Instrument for Adults (HAPI-A): the psychometric properties of a level of functioning assessment instrument designed for use in a state managed care mental health program.

Authors:  John McGrew; Frederick L Newman; Richard N DeLiberty
Journal:  Community Ment Health J       Date:  2007-07-10

7.  An economic and clinical rationale for changing utilization review practices for outpatient psychotherapy.

Authors:  K D Hennessy; S Green-Hennessy
Journal:  J Ment Health Adm       Date:  1997

Review 8.  Neuroimaging for psychotherapy research: current trends.

Authors:  Carol P Weingarten; Timothy J Strauman
Journal:  Psychother Res       Date:  2014-02-17

9.  [Adaptive indication in outpatient psychodynamic short-term psychotherapy. Results of a prospective naturalistic research study].

Authors:  C E Scheidt; T Burger; S Strukely
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214

10.  Treatment progress indicator: application of a new assessment tool to objectively monitor the therapeutic progress of patients with depression, anxiety, or behavioral health impairment.

Authors:  Phillip Tuso
Journal:  Perm J       Date:  2014-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.